Life science and health care professionals, as well as consumers, are invited to attend the 6th Digital Strategy & Innovation for Medical Affairs Summit on November 2-3, 2022. Participating pharma and medical companies can learn how to streamline their medical department affairs using innovative digital transformation policies that experts share and discuss at the DGE event.
The event is organized by Dynamic Global Events (“DGE”), a leading life science B2B event organizing company. The 6th Digital Strategy Summit is the largest event devoted to the medical industry that is being streamed live on an established interactive platform. The event will witness life science experts of global acclaim sharing a common platform at the symposium. They will offer valuable advice on successfully employing digital strategies to stay relevant. The evolving landscape of the medical arena owing to COVID-19 makes it essential to design futuristic digital marketing strategies.
Attendees can benefit from an all-access ticket to three DGE events. Register for DGE’s 3rd Next-Gen MSL Excellence or the 2nd Investigator-Initiated Trials Summit, and attend sessions from any of the events.
The featured discussions at the Summit:
- Harness the potential of novel technologies for better growth and development
- Improvise the regulations for accommodating digital health practices
- Learn about new avenues to engage with stakeholders
- Design-customer centric strategies
- Engage audiences effectively using media and messaging
- Best practices for cross-functional collaboration among teams
- Robust social media strategies for expanding outreach
- Learn new ways to shape omnichannel outreach
As patients get access to multiple channels of medical and scientific information, every medical affairs team has to stay updated with the new technologies and evolving marketing strategies. Biotech, pharma, and life science organizations, must all evolve and look for new ways to engage the audience. Experts will speak about the importance of Real World Evidence and how it can be a game-changer in benefitting the organization as a whole.
Multichannel digital strategies by small and mid-size companies can play a pivotal role in disease state education and clinical trial awareness for stakeholders, especially in the case of rare diseases. Learn strategies and tips for digital innovation to ensure that data reaches the stakeholders as and when they need it. Also, discover new publication amplification strategies to increase visibility and engagement.
To learn more, please visit https://ibn.fm/2MrTz.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.